Cantor Fitzgerald analyst Josh Schimmer reiterated an Overweight rating on Cabaletta Bio Inc. (NASDAQ: CABA).The analyst commented, "The IND clearance ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE